TORONTO–(BUSINESS WIRE)–Today, women make up 50% of university students enrolled in STEM and health programs in Canada.1 Women identifying as visible minorities make up...

We’re announcing three new members to our Board of Directors as a first step towards our commitment to expansion: Dr. Sue Desmond-Hellmann, former CEO...

DUBLIN–(BUSINESS WIRE)–The “Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, with Executive & Consultant Guides and Market Analysis & Forecasts 2022-2026” report...

<a data-fancybox data-src="https://coingenius.news/wp-content/uploads/2024/02/first-in-human-study-reveals-potential-of-biology-guided-radiotherapy-physics-world.jpg" data-caption="Inside the machine Key components of the RefleXion X1 radiotherapy system: 1) 6 MeV electron beam linac; 2) multileaf collimator; 3)...

AI algorithms used to determine eligibility for US government healthcare coverage are increasingly verboten, the federal agency Centers for Medicare & Medicaid Services (CMS)...

This is a guest post co-authored by Ajay K Gupta, Jean Felipe Teotonio and Paul A Churchyard from HSR.health. HSR.health is a geospatial health...

Aggregating channels with precision outreach to patients, family members, and oncologists/hematologists improves clinical research access for all MALMO, Sweden & NEW YORK–(BUSINESS WIRE)–Trialbee, your global...

U.S. Senator Rand Paul, in his recent interview on Fox Business, provided a critical overview of the United States’ role in global financial aid...

An AI chatbot was better at diagnosing medical ailments and communicating results than human physicians in text-based conversations, a research paper from Google claims.  The...

IRVINE, Calif.–(BUSINESS WIRE)–#ClinicalTrials—Immunis, Inc., a private biotech pioneering cellular secretome treatments to address age and disease-related immune decline, presents a one-of-a-kind film (The Time...

Utilizing patented nanosensors fueling transformative AI, SimpleSenseTM, is the first wearable platform that enables physicians to securely and accurately offer patients full routine cardiopulmonary...

ZELSUVMI™ is expected to be commercially available during the second half of 2024 SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that the U.S....